Adverse events following immunization of COVID‐19 (Covaxin) vaccine at a tertiary care center of India

Author:

Parida Swayam Pragyan1ORCID,Sahu Dinesh Prasad1ORCID,Singh Arvind Kumar1ORCID,Alekhya G.1ORCID,Subba Sonu Hangma1ORCID,Mishra Abhisek1ORCID,Padhy Biswa Mohan2,Patro Binod Kumar1ORCID

Affiliation:

1. Department of Community Medicine and Family Medicine All India Institute of Medical Sciences Bhubaneswar Odisha India

2. Department of Pharmacology All India Institute of Medical Sciences Bhubaneswar Odisha India

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference26 articles.

1. WHO. Coronavirus Disease (COVID‐19) Dashboard WHO Coronavirus Disease (COVID‐19) Dashboard.  Accessed September 20 2021. https://covid19.who.int/

2. Ministry of Health and Family Welfare Government of India. COVID‐19 India. Accessed September 20 2021. https://www.mohfw.gov.in/

3. Ministry of Science and Technology. DBT‐BIRAC supported ZyCoV‐D developed by Zydus Cadila Receives Emergency Use Authorization. Press Information Bureau. Accessed September 20 2201. https://pib.gov.in/PressReleasePage.aspx?PRID=1747669

4. Press Information Bureau. PIB'S bulletin on COVID‐19. PIB headquarters. Accessed September 20 2021.https://pib.gov.in/PressReleasePage.aspx?PRID=1743567

5. Ministry of Health and Family Welfare. The national regulator grants permission for restricted use in emergency situations to Sputnik‐V vaccine. Press Information Bureau. Accessed September 20 2021. https://pib.gov.in/PressReleasePage.aspx?PRID=1711342

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3